FDA approves ImmunityBio's bladder cancer treatment
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio’s treatment for a type of bladder cancer.
Stay updated with breaking news from Altor Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio’s treatment for a type of bladder cancer.
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer.
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced a new...
/PRNewswire/ -- The "Global Genomics Partnering Terms and Agreements 2016 to 2023" report has been added to ResearchAndMarkets.com's offering. The Global...
MIRAMAR, Fla., May 09, 2023 -- HCW Biologics Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the... | May 9, 2023